Caption Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Caption Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-305,800	Closed	-$8.56M	–	1809
2025 Q2	$8.56M	Buy	+305,800	New	+$8.2M	0.09%	254
2025 Q1	–	Sell	-45,100	Closed	-$1.24M	–	1715
2024 Q4	$1.24M	Buy	+45,100	New	+$1.26M	0.01%	852
2023 Q4	–	Sell	-45,000	Closed	-$1.55M	–	1462
2023 Q3	$1.55M	Buy	45,000 +15,000	+50%	+$584K	0.02%	646
2023 Q2	$1.22M	Sell	30,000 -31,900	-52%	-$1.3M	0.02%	621
2023 Q1	$2.39M	Hold	61,900	–	–	0.05%	404
2022 Q4	$2.75M	Buy	+61,900	New	+$2.6M	0.04%	470
2022 Q2	–	Sell	-30,000	Closed	-$1.86M	–	1585
2022 Q1	$1.86M	Sell	30,000 -15,000	-33%	-$918K	0.02%	778
2021 Q4	$2.48M	Sell	45,000 -35,000	-44%	-$1.83M	0.03%	717
2021 Q3	$4.21M	Sell	80,000 -89,500	-53%	-$5.31M	0.05%	522
2021 Q2	$11.7M	Sell	169,500 -4,000	-2%	-$305K	0.15%	168
2021 Q1	$13.4M	Buy	173,500 +55,000	+46%	+$5.07M	0.29%	71
2020 Q4	$11.7M	Buy	+118,500	New	+$14.5M	0.27%	95

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caption Management's LKFT Position: Q2 2023 in Review

Caption Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2023, closing a stake of 19,826 shares — an estimated $809K sold.

Caption Management first reported a position in LKFT in Q4 2020 and held it in 8 quarters. The position peaked at $5.52M in Q1 2021. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2023.

Caption Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Caption Management sold 19,826 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2023, an estimated $809K.
Caption Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2020 and held it in 8 quarters.
Caption Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $5.52M in Q1 2021.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2023.

Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.